Please login to the form below

Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016

The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

The awards have been specifically designed to recognise and commend excellence, best practice and innovation on a local and global scale, with programmes demonstrating a meaningful change in outcomes for patients.

2016 also marks the start of a new category - PMEA Support Agency of the Year. This category recognises excellent work from companies in support sectors who have provided their pharmaceutical clients with outstanding assistance across their businesses. The four categories Lucid entered and have been shortlisted in are:

PMEA Support Agency of the Year –
Lucid Group

Innovation – Advance Outcomes® – An Innovative Model of Medical Education to Achieve Improved, Measurable Healthcare and Patient Outcomes

Excellence in Healthcare Collaboration and Partnerships – The Ulcerative Colitis Endoscopic Index of Severity Online Tool

Excellence in Physicians / Healthcare Provider Support Programmes – PEER: Psoriasis Expert Exchange FoRum: Changing clinical behaviour on a global scale to improve standards of care in the management of psoriatic arthritis.

Dennis O’Brien (Lucid Co-founder and CEO) commented “We are delighted to have made the shortlist in all four categories we entered, in particular we are very proud to be finalists in the new category of PMEA Support Agency of the Year. We aim to improve patient outcomes in everything we do, and it is fantastic to be recognised for the support we provide.”

12th October 2016